Development of an Intranasal Proteosome Influenza Vaccine
Clinical trial NCT02522754 · COMPLETED
Trial details
- NCT number
- NCT02522754
- Sponsor
- Hvivo
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2004-01-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.